The RCMI Program in Health Disparities Research at Meharry Medical College

梅哈里医学院 RCMI 健康差异研究项目

基本信息

  • 批准号:
    9974573
  • 负责人:
  • 金额:
    $ 423.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-30 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

The RCMI Program in Health Disparities Research at Meharry Medical College (RHDR@MMC) proposes to address health disparities at multiples scales of research: from micro to macro environments. With institutional collaboration and support, this application continues the long-term RCMI support of enabling high quality basic, behavioral, and clinical research to eliminate health disparities as our long-term goal. The RHDR@MMC is not discipline or disease focused, but emphasizes the disruption of disparity at all scales, from proteins to the human ecosystems of the populations we serve. Our re-envisioned Research Infrastructure Core will provide expert technical support in areas relevant to the research projects, as well as services such as design, biostatistics, bio and health informatics, and cross-training support to benefit ALL researchers at the institution. We have assembled a cadre of scientists including basic, behavioral, dental clinicians, population-based, and community-engaged researchers at Meharry to participate in this endeavor. Our aims are to: 1. Support four outstanding research projects addressing HIV-AIDS, prostate cancer, racial and ethnic differences in periodontal disease microbiomes, and adversity-driven chronic pain to advance fundamental understanding of these health disparities. 2. Strengthen core technologies and expand bioinformatics and biostatistical services supporting the four research projects, as well as all Meharry research faculty, to increase institutional success in extramural funding studying diseases that disproportionally affect minority and other health disparity populations. 3. Nurture an environment conducive to developing new and early career investigators by facilitating a mentorship network, enhancing professional developmental activities, and providing pilot project funds. 4. Improve and expand relationships with community-based organizations that partner with Meharry. 5. Recruit outstanding magnet scientists to energize current faculty and contribute to our research capacity in cancers of the underserved, infectious diseases including HIV-AIDS, disparity-causing differences in microbiomes of minorities, and societal adversity leading to debilitating chronic pain in African Americans.
Meharry医学院的RCMI健康差异研究计划(RHDR@MMC)建议, 在从微观到宏观环境的多个研究尺度上解决健康差距问题。与机构 协作和支持,该应用程序继续长期RCMI支持,使高质量的基本, 行为和临床研究,以消除健康差距作为我们的长期目标。RHDR@MMC不是 学科或疾病为重点,但强调在所有尺度上的差异,从蛋白质到 我们所服务的人类生态系统。我们重新设想的研究基础设施核心将提供 在与研究项目相关的领域提供专家技术支持,以及设计, 生物统计学,生物和健康信息学,以及交叉培训支持,使该机构的所有研究人员受益。 我们已经召集了一批科学家,包括基础、行为、牙科临床医生、基于人群的, 社区参与的研究人员在Meharry参与这一奋进。我们的目标是: 1.支持四个杰出的研究项目,解决艾滋病毒/艾滋病,前列腺癌,种族和民族 牙周病微生物组的差异,以及逆境驱动的慢性疼痛, 了解这些健康差异。 2.强化核心技术,拓展生物信息学和生物统计学服务支撑四个 研究项目,以及所有的梅哈里研究教师,以增加在校外机构的成功 资助研究对少数民族和其他健康不平等人口造成不良影响的疾病。 3.通过促进以下方式,营造有利于培养新的和早期职业调查员的环境: 导师网络,加强专业发展活动,并提供试点项目资金。 4.改善和扩大与Meharry合作的社区组织的关系。 5.招募优秀的磁铁科学家,以激励现有的教师,并有助于我们的研究能力, 癌症,包括艾滋病毒/艾滋病在内的传染病, 少数民族的微生物组,以及导致非裔美国人衰弱的慢性疼痛的社会逆境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Samuel Evans Adunyah其他文献

Samuel Evans Adunyah的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Samuel Evans Adunyah', 18)}}的其他基金

Admin Core
管理核心
  • 批准号:
    10889326
  • 财政年份:
    2023
  • 资助金额:
    $ 423.08万
  • 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
MMC、VICC
  • 批准号:
    8534727
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
  • 批准号:
    9356457
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
  • 批准号:
    10012757
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
  • 批准号:
    9211638
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
1/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
  • 批准号:
    10493417
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
Education and Training Core
教育培训核心
  • 批准号:
    10493432
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
Education and Training Core
教育培训核心
  • 批准号:
    10327937
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
Administration Core
行政核心
  • 批准号:
    8261507
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
  • 批准号:
    9765041
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 423.08万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 423.08万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 423.08万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 423.08万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 423.08万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 423.08万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 423.08万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 423.08万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 423.08万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 423.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了